Unknown

Dataset Information

0

Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation.


ABSTRACT: Glioblastoma (GBM) is a lethal cancer characterized by hypervascularity and necrosis associated with hypoxia. Here, it is found that hypoxia preferentially induces the actin-binding protein, Transgelin (TAGLN), in GBM stem cells (GSCs). Mechanistically, TAGLN regulates HIF1α transcription and stabilizes HDAC2 to deacetylate p53 and maintain GSC self-renewal. To translate these findings into preclinical therapeutic paradigm, it is found that sodium valproate (VPA) is a specific inhibitor of TAGLN/HDAC2 function, with augmented efficacy when combined with natural borneol (NB) in vivo. Thus, TAGLN promotes cancer stem cell survival in hypoxia and informs a novel therapeutic paradigm.

SUBMITTER: Li H 

PROVIDER: S-EPMC10870072 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


Glioblastoma (GBM) is a lethal cancer characterized by hypervascularity and necrosis associated with hypoxia. Here, it is found that hypoxia preferentially induces the actin-binding protein, Transgelin (TAGLN), in GBM stem cells (GSCs). Mechanistically, TAGLN regulates HIF1α transcription and stabilizes HDAC2 to deacetylate p53 and maintain GSC self-renewal. To translate these findings into preclinical therapeutic paradigm, it is found that sodium valproate (VPA) is a specific inhibitor of TAGLN  ...[more]

Similar Datasets

| S-EPMC5175153 | biostudies-literature
| S-EPMC6393469 | biostudies-literature
| S-EPMC4909547 | biostudies-literature
| S-EPMC3739090 | biostudies-other
| S-EPMC5436539 | biostudies-literature
| S-EPMC7596047 | biostudies-literature
| S-EPMC2660897 | biostudies-literature
| S-EPMC10217433 | biostudies-literature
| S-EPMC10842612 | biostudies-literature
| S-EPMC6801103 | biostudies-literature